ArticleMolecular diversity2025

Machine learning-based screening and molecular simulations for discovering novel PARP-1 inhibitors targeting DNA repair mechanisms for breast cancer therapy.

Muhammad Shahab et al.PubMed ↗Publisher ↗

No numbers read from the abstract.